Daebong LS Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Daebong LS Company Limited with three other
companies in this sector in South Korea:
Ilsung Pharmaceuticals Company Limited
sales of 67.04 billion Korean Won [US$59.06 million]
of which 100%
was Pharmaceutical Business),
Korea Arlico Pharm Co Ltd
(71.36 billion Korean Won [US$62.87 million]
Sam-A Pharmaceutical Company
(61.79 billion Korean Won [US$54.44 million]
Daebong LS Company Limited reported sales of 65.65 billion Korean Won (US$57.84 million)
December of 2017.
decrease of 7.6%
versus 2016, when the company's sales were 71.04 billion Korean Won.
Contributing to the drop in overall sales was the 45.4% decline
in Wholesale, from 1.22 billion Korean Won to 668.82 million Korean Won.
There were also decreases in sales in
Manufacturing (down 10.6% to 56.67 billion Korean Won)
However, these declines were partially offset by the increase in sales of
Research (up 28.8% to 8.31 billion Korean Won)